Literature DB >> 5230426

Drug accumulation.

J G Wagner.   

Abstract

Mesh：

Substances：

Year:  1967        PMID： 5230426     DOI： 10.1002/j.1552-4604.1967.tb00290.x

Source DB:  PubMed          Journal:  J Clin Pharmacol J New Drugs        ISSN： 0095-9863


× No keyword cloud information.
  12 in total

Review 1.  The phenomenon and rationale of marked dependence of drug concentration on blood sampling site. Implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics (Part II).

Authors:  W L Chiou
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447

2.  Bioavailability and absorption kinetics of nicotine following application of a transdermal system.

Authors:  S K Gupta; N L Benowitz; P Jacob; C N Rolf; J Gorsline
Journal:  Br J Clin Pharmacol       Date:  1993-09       Impact factor: 4.335

3.  Pharmacokinetics of orally administered acetaminophen in man.

Authors:  K S Albert; A J Sedman; J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1974-10

4.  Single- and multiple-dose kinetics of oral lorazepam in humans: the predictability of accumulation.

Authors:  D J Greenblatt; M D Allen; D S MacLaughlin; D H Huffman; J S Harmatz; R I Shader
Journal:  J Pharmacokinet Biopharm       Date:  1979-04

5.  Formal theory of discrete drug dosing regimen adjustments.

Authors:  I Janků
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

6.  Pharmacokinetics of ketoprofen following single oral, intramuscular and rectal doses and after repeated oral administration.

Authors:  T Ishizaki; T Sasaki; T Suganuma; Y Horai; K Chiba; M Watanabe; W Asuke; H Hoshi
Journal:  Eur J Clin Pharmacol       Date:  1980-11       Impact factor: 2.953

7.  Tissue Penetration of a Novel Spectinamide Antibiotic for the Treatment of Tuberculosis.

Authors:  Dora Babu Madhura; Ashit Trivedi; Jiuyu Liu; Vincent A Boyd; Cynthia Jeffries; Vivian Loveless; Richard E Lee; Bernd Meibohm
Journal:  AAPS J       Date:  2016-03-16       Impact factor: 4.009

8.  Pharmacokinetics of chlorpheniramine after intravenous and oral administration in normal adults.

Authors:  S M Huang; N K Athanikar; K Sridhar; Y C Huang; W L Chiou
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

9.  Pharmacokinetics and safety of ebastine in healthy subjects and patients with renal impairment.

Authors:  Robert J Noveck; Richard A Preston; Suzanne K Swan
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

10.  Pharmacokinetics and safety of ebastine in patients with impaired hepatic function compared with healthy volunteers: a phase I open-label study.

Authors:  Kenneth C Lasseter; Stacy C Dilzer; Ramon Vargas; Scott Waldman; Robert J Noveck
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.